Healthcare provider profile · identity verified

Bruce C Waskowicz, M.D.

Family Practice · EAST EARL, PA · NPI 1558378760

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	649	175
Lisinopril	Lisinopril	366	89
Levothyroxine Sodium	Levothyroxine Sodium	309	57
Amlodipine Besylate	Amlodipine Besylate	289	75
Metformin Hcl	Metformin Hcl	238	65
Hydrochlorothiazide	Hydrochlorothiazide	227	56
Sertraline Hcl	Sertraline Hcl	226	58
Omeprazole	Omeprazole	195	58
Simvastatin	Simvastatin	172	46
Metoprolol Succinate	Metoprolol Succinate	167	41
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	157	42
Losartan Potassium	Losartan Potassium	141	40
Pantoprazole Sodium	Pantoprazole Sodium	138	36
Rosuvastatin Calcium	Rosuvastatin Calcium	136	34
Glimepiride	Glimepiride	126	32
Tamsulosin Hcl	Tamsulosin Hcl	126	30
Gabapentin	Gabapentin	114	28
Prednisone	Prednisone	104	88
Metoprolol Tartrate	Metoprolol Tartrate	98	22
Famotidine	Famotidine	92	22
Clopidogrel	Clopidogrel Bisulfate	87	19
Finasteride	Finasteride	86	22
Furosemide	Furosemide	86	21
Eliquis	Apixaban	72	14
Irbesartan	Irbesartan	70	18
Trulicity	Dulaglutide	69	11
Escitalopram Oxalate	Escitalopram Oxalate	65	19
Allopurinol	Allopurinol	62	18
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	60	11
Farxiga	Dapagliflozin Propanediol	60	11
Pravastatin Sodium	Pravastatin Sodium	59	18
Xarelto	Rivaroxaban	58	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	57	12
Januvia	Sitagliptin Phosphate	54	12
Alprazolam	Alprazolam	53	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	52	suppressed
Meloxicam	Meloxicam	50	30
Venlafaxine Hcl Er	Venlafaxine Hcl	49	suppressed
Fluticasone Propionate	Fluticasone Propionate	46	12
Lorazepam	Lorazepam	46	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	45	43
Citalopram Hbr	Citalopram Hydrobromide	45	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	45	suppressed
Metformin Hcl Er	Metformin Hcl	45	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	12
Pregabalin	Pregabalin	44	suppressed
Alendronate Sodium	Alendronate Sodium	43	suppressed
Risedronate Sodium	Risedronate Sodium	43	suppressed
Fenofibrate	Fenofibrate	42	11
Tradjenta	Linagliptin	42	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	41	suppressed
Carvedilol	Carvedilol	39	11
Mounjaro	Tirzepatide	38	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	38	26
Azithromycin	Azithromycin	37	37
Synthroid	Levothyroxine Sodium	37	suppressed
Jardiance	Empagliflozin	35	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	33	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	13
Potassium Chloride	Potassium Chloride	33	suppressed
Trazodone Hcl	Trazodone Hcl	33	11
Montelukast Sodium	Montelukast Sodium	32	suppressed
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	29	18
Breo Ellipta	Fluticasone/Vilanterol	29	suppressed
Tramadol Hcl	Tramadol Hcl	29	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	28	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	20
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	26	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Ozempic	Semaglutide	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	13
Novolog Flexpen	Insulin Aspart	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Valsartan	Valsartan	23	suppressed
Amoxicillin	Amoxicillin	21	12
Atenolol	Atenolol	21	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	20	suppressed
Invokana	Canagliflozin	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Cephalexin	Cephalexin	18	16
Spironolactone	Spironolactone	18	suppressed
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Duloxetine Hcl	Duloxetine Hcl	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	11	suppressed
Fosinopril Sodium	Fosinopril Sodium	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Ramipril	Ramipril	11	suppressed
Risperidone	Risperidone	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	11
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error